HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 224 filers reported holding HORIZON PHARMA PLC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,197,000 | +27.5% | 158,800 | -5.8% | 0.23% | +6.9% |
| Q4 2018 | $3,292,000 | -24.1% | 168,500 | -24.0% | 0.22% | -21.5% |
| Q3 2018 | $4,340,000 | +36.8% | 221,678 | +15.7% | 0.28% | +1.5% |
| Q2 2018 | $3,173,000 | -72.6% | 191,578 | -75.9% | 0.27% | -77.6% |
| Q4 2017 | $11,593,000 | +87.8% | 794,062 | +63.2% | 1.21% | +87.5% |
| Q3 2017 | $6,173,000 | +27.6% | 486,463 | +19.4% | 0.65% | +12.9% |
| Q2 2017 | $4,836,000 | -34.4% | 407,398 | -18.3% | 0.57% | -41.8% |
| Q1 2017 | $7,372,000 | +1800.0% | 498,765 | +1978.2% | 0.98% | +1143.0% |
| Q4 2016 | $388,000 | -81.7% | 24,000 | -79.5% | 0.08% | -79.4% |
| Q3 2016 | $2,121,000 | +10.1% | 117,000 | 0.0% | 0.38% | +5.5% |
| Q2 2016 | $1,927,000 | -62.5% | 117,000 | -62.3% | 0.36% | -61.1% |
| Q1 2016 | $5,137,000 | – | 310,000 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,609,894 | $109,460,000 | 3.84% |
| Avoro Capital Advisors LLC | 5,593,683 | $92,631,000 | 3.57% |
| Broadfin Capital, LLC | 1,339,575 | $22,183,000 | 3.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 11,912,290 | $197,268,000 | 3.45% |
| JW Asset Management, LLC | 270,775 | $4,484,000 | 2.86% |
| Rhenman & Partners Asset Management AB | 1,632,212 | $27,029,000 | 2.77% |
| Paulson & Co. | 7,670,700 | $127,027,000 | 2.60% |
| Redwood Investments, LLC | 1,315,149 | $21,779,000 | 1.50% |
| KOPP INVESTMENT ADVISORS LLC | 93,220 | $1,544,000 | 1.45% |
| 1492 Capital Management LLC | 72,951 | $1,208,000 | 0.86% |